Group by: Item Type | No Grouping
Jump to: Article
Number of items: 18.

Article

Alabas, OA, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Yiu, ZZN, Hampton, PJ, Reynolds, NJ, Owen, CM, Bewley, A, Laws, PM, Warren, RB, Lunt, M, Smith, CH and Griffiths, CEM (2023) Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR. British Journal of Dermatology.

Alabas, O, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Yiu, Z, Warren, R, Lunt, M, Smith, C and Griffiths, C (2022) Real-world effectiveness and persistence of methotrexate versus adalimumab: A comparative study from the British association of dermatologists biologics and immunomodulators register (BADBIR). Pharmacoepidemiology and Drug Safety, 31 (S2). 490 - 490.

Cordingley, L, Nelson, PA, Davies, L, Ashcroft, D, Bundy, C, Chew-Graham, CA ORCID: https://orcid.org/0000-0002-9722-9981, Chisholm, A, Elvidge, J, Hamilton, M, Hilton, R, Kane, K, Keyworth, C, Littlewood, A, Lovell, K, Lunt, M, McAteer, H, Ntais, D, Parisi, R, Pearce, C, Rutter, M, Symmons, D, Young, H and Griffiths, CEM (2022) Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme. Programme Grants for Applied Research, 10 (3). 1 - 240.

Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Burden, AD, Barker, JNWN, Lunt, M, Ali, H, Kleyn, CE, McElhone, K, Soliman, MM, Green, AC, Griffiths, CEM, Reynolds, NJ and Ormerod, AD (2021) Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology.

Yiu, ZZN, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Hampton, PJ, Reynolds, NJ, Smith, CH, Lunt, M, Griffiths, CEM and Warren, RB (2020) Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register. JAMA Dermatology.

Stedman, M, Lunt, M, Davies, M, Livingston, M, Duff, C, Fryer, AA ORCID: https://orcid.org/0000-0001-8678-0404, Anderson, SG, Gadsby, R, Gibson, M, Rayman, G and Heald, A (2020) Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation. BMJ Open, 10 (5). e033231 - ?.

Yiu, ZZN, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Hampton, PJ, Reynolds, NJ, Smith, CH, Lunt, M, Griffiths, CEM and Warren, RB (2020) Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). British Journal of Dermatology, 183 (2). 294 - 302.

Rungapiromnan, W, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Lunt, M, McElhone, K, Rutter, MK, Warren, RB, Griffiths, CEM, Ashcroft, DM and Grp, BADBIRS (2019) Risk of major cardiovascular events in adult patients with psoriasis treated with biologic therapies or methotrexate: Cohort study in the British Association of Dermatologists Biologic Interventions Register (BADBIR). Pharmacoepidemiology and Drug Safety, 27. 467 - 467.

Rungapiromnan, W, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Lunt, M, McElhone, K, Burden, AD, Rutter, MK, Warren, RB, Griffiths, CEM, Ashcroft, DM and Study Group, BADBIR (2019) Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study. Journal of the European Academy of Dermatology and Venereology, 34 (4). 769 - 778.

Heald, A, Davies, M, Stedman, M, Livingston, M, Lunt, M, Fryer, AA ORCID: https://orcid.org/0000-0001-8678-0404 and Gadsby, R (2019) Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes. BMJ Open, 9 (9). e028278 - ?.

Yiu, ZZN, Sorbe, C, Lunt, M, Rustenbach, SJ, Kühl, L, Augustin, M, Mason, KJ, Ashcroft, DM, Griffiths, CEM and Warren, RB (2019) Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy. British Journal of Dermatology, 180 (4). 894 -901.

Yiu, ZZN, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Barker, JNWN, Hampton, PJ, McElhone, K, Smith, CH, Warren, RB, Griffiths, CEM, Lunt, M, Burden, AD and Study Group, BADBIR (2019) A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis. British Journal of Dermatology, 181 (6). 1265 - 1271.

Heald, AH, Livingston, M, Fryer, AA ORCID: https://orcid.org/0000-0001-8678-0404, Cortes, G, Anderson, SG, Gadsby, R, Laing, I, Lunt, M, Young, RJ and Stedman, M (2018) Real-world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes. International Journal of Clinical Practice, 72 (12). e13252 - ?.

Yiu, ZZN, Ashcroft, DM, Evans, I, McElhone, K ORCID: https://orcid.org/0000-0002-5419-0669, Lunt, M, Smith, CH, Walton, S, Murphy, R, Reynolds, NJ, Ormerod, AD, Griffiths, CEM, Warren, RB and Study Group, BADBIR (2018) Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British Journal of Dermatology, 180 (2). 329 - 337.

Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Barker, JNWN, Smith, CH, Hampton, PJ, Lunt, M, McElhone, K, Warren, RB, Yiu, ZZN, Griffiths, CEM, Burden, AD and Study Group, BADBIR (2018) Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR. JAMA Dermatology, 154 (5). 581 - 588.

Druce, KL, Cordingley, L, Short, V, Moore, S, Hellman, B, James, B, Lunt, M, Kyle, SD, Dixon, WG and McBeth, J (2018) Quality of life, sleep and rheumatoid arthritis (QUASAR): a protocol for a prospective UK mHealth study to investigate the relationship between sleep and quality of life in adults with rheumatoid arthritis. BMJ Open, 8 (1). e018752 - ?.

Iskandar, IYK, Warren, RB, Lunt, M, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Evans, I, McElhone, K, Smith, CH, Reynolds, NJ, Ashcroft, DM, Griffiths, CEM and Study Group, BADBIR (2017) Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology, 138 (4). 775 - 784.

Rutter, MK, Kane, K, Lunt, M, Cordingley, L, Littlewood, A, Young, HS, Chew-Graham, CA, Hilton, R, Symmons, DPM and Griffiths, CEM (2016) Primary care-based screening for cardiovascular risk factors in patients with psoriasis. British Journal of Dermatology, 175 (2). 348 -356.

This list was generated on Wed Nov 1 01:00:34 2023 UTC.